Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies

NCT05983146 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped The sponsor's R\&D strategy is adjusted.

Conditions

Advanced Malignant Cancer

Interventions

DRUG: HRS-7053 Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.